Quest Diagnostics Q2 Revenues Rise 4 Percent, Beat Analyst Estimates | GenomeWeb

NEW YORK (GenomeWeb) – Quest Diagnostics today reported a 4 percent increase year over year in its second quarter revenues, as the company narrowly beat consensus analyst estimates on the top and bottom lines.

Quest reported that for the three months ending June 30, it had $1.90 billion in revenues, up from $1.82 billion in the year-ago quarter. The average analyst estimate was for $1.88 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.